INNOVATIVE TECHNOLOGIES FOR ENHANCING FUNCTION FOR INDIVIDUALS WITH 
DISABILITIES - PA-02-071 - ADDENDUM

Release Date:  March 21, 2002

NOTICE:  NOT-DA-02-006

National Institute on Drug Abuse (NIDA)
 (www.nida.nih.gov)

PURPOSE

This addendum is to program announcement PA-02-071, which was released 
in the NIH Guide for Grants and Contracts on March 4, 2002 at 
https://grants.nih.gov/grants/guide/pa-files/PA-02-071.html.
This purpose of this program announcement is to encourage basic 
research on the structures of membrane proteins at atomic resolution.                   
This addendum adds the National Institute on Drug Abuse (NIDA) as a 
participating institute in this program announcement.

The following are NIDA contacts:

Direct inquiries regarding programmatic issues to:

Charles Sharp, Ph.D.
Division of Neuroscience and Behavioral Research
National Institute on Drug Abuse
6001 Executive Boulevard, Room 4282, MSC 9581
Bethesda, MD  20892-9555
Telephone: (301)-443-1887
Fax: 301-594-6043
E-mail:  csharp@nida.nih.gov

Direct inquiries regarding fiscal matters to:

Gary Fleming, J.D., M.A.
Grants Management Branch
National Institute on Drug Abuse
6001 Executive Boulevard, Room 3158, MSC 9541
Bethesda, MD  20892-9541
Telephone: (301)-443-6710
E-mail: gf6s@nih.gov

Return to Volume Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER) 		  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892 		  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) 		  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.